| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3199129 | Journal of Allergy and Clinical Immunology | 2012 | 11 Pages |
Abstract
Reslizumab significantly reduced intraepithelial esophageal eosinophil counts in children and adolescents with eosinophilic esophagitis. However, improvements in symptoms were observed in all treatment groups and were not associated with changes in esophageal eosinophil counts.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jonathan M. MD, PhD, Marc E. MD, PhD, Margaret H. MD, Glenn T. MD, Jonathan E. MD, George MD, Molly A. MD, Juan Pablo MD, James MS, Timothy MD, PhD, H. Jeffrey MD, Chris A. MD,